As of February 6, 2026, Philip Morris International (NYSE: PM) stands at a historic crossroads. Long regarded as the quintessential "Big Tobacco" play, the company has spent the last decade aggressively cannibalizing its own legacy combustible business to lead a global "smoke-free" revolution. Today, the results of this gamble are no longer speculative; they are [...]
Tobacco company Philip Morris International (NYSE:PM) met Wall Streets revenue expectations in Q4 CY2025, with sales up 6.8% year on year to $10.36 billion. Its non-GAAP profit of $1.70 per share was in line with analysts’ consensus estimates.
Wall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Philip Morris has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.2% to $172.32 per share while the index has gained 8.2%.
Join us as we dissect Philip Morris International's stock performance and explore whether it can thrive in a changing market landscape. Will it be a solid investment or a risky bet?
Philip Morris asked the FDA to allow reduced-risk claims for ZYN, citing advisory-panel-reviewed evidence that switching from cigarettes lowers several disease risks.
